1 of 1
Story summary
- A University of Sydney review in Human Reproduction Update finds the intrauterine hCG add-on used in IVF does not improve pregnancy or live-birth rates.
- The meta-analysis pooled seven randomized trials with 2,244 patients and showed no benefit across fresh or frozen transfers, embryo stages, or doses.
- Experts note the $50-$100 add-on is listed without separate pricing and warn it exemplifies broader concerns about IVF add-ons based on weak trial data.
